ICHIF yields 2.44% · JNJ yields 2.13%● Live data
📍 ICHIF pulled ahead of the other in Year 1
Combined, ICHIF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ICHIF + JNJ for your $10,000?
Ichigo Inc. owns and operates real estate properties in Japan. The company manages J-REIT and private equity real estate funds; and develops small-and mid-size assets and ground leases. It also acquires, manages, leases, and sells real estate properties. In addition, the company produces and supplies clean energy; and provides engineering, consulting, and technical solutions. Further, it is involved in the building and operation of solar power plants; and operating self-storage facilities. Additionally, the company, through its subsidiary, Ichigo Animation, is involved in the planning, editing, developing, streaming, distributing, and import/export of printed and digital content; planning, developing, creating, streaming, and domestic and overseas distribution of films and content for streaming, TV, and other media; planning, developing, and distribution of scripts; planning, manufacturing, sale, and import/export of character-themed products, toys, household products, apparel, accessories, stationary, household electronics, shoes, and bags. As of December 10, 2021, it operated 58 solar power plants. The company was formerly known as Ichigo Group Holdings Co., Ltd. and changed its name to Ichigo Inc. in August 2015. Ichigo Inc. was incorporated in 2000 and is based in Tokyo, Japan.
Full ICHIF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.